Happy Mothers Breastfed Babies
  Forgot Your LLLID? or Create Your LLLID Here
La Leche League International
To Find local support:  Or: Use the Map

Vitamin D Requirements During Infancy:
Reading Between the Lines

Heather Will, MD, Sarah N. Taylor, MD, and Carol L. Wagner, MD
Division of Neonatology, Department of Pediatrics, Medical University of South Carolina,
Charleston, SC, USA
From: Leaven, Vol. 45 No. 1, 2009, pp. 2-6.


Pregnancy and lactation represent unique time periods in human development where the health and nutritional status of one individual, the mother, directly impacts another, the fetus or infant. Expanding knowledge about vitamin D during these time periods has illuminated the role of vitamin D on maternal and infant bone health, cardiovascular health, immune function, and glucose metabolism. Despite these findings, studies continue to report extensive vitamin D insufficiency and deficiency during pregnancy and lactation that particularly affect women and their offspring who are of darker pigmentation, living at higher latitudes, and in the winter season. Caution must be taken with experimentation during these critical periods of human development, but also must proceed expeditiously as available research indicates long term health consequences of continued vitamin D insufficiency and deficiency.

Historical Perspective

Historical writings of bony deformities resembling rickets date back as far as the first century Greek and Roman writings but the definitive description emerged in the mid 17th century (1-3). In 1645, an English medical student by the name of Daniel Whistler first published a description of the disease, which was rampant in southwest England (1-3). In 1650, Francis Glissen published a more scientific report on rickets, which remains a classic historic resource on the disease (1-4). The following two centuries led to little advancement in the understanding or treatment of rickets (5). By the early 20th century, rickets was epidemic in the northern, industrialized regions of the United States and Europe with 96 percent of infants demonstrating microscopic findings of the disease at autopsy (5,6). In 1919, Edward Mellanby conducted the first experiment designed to find the underlying cause and possible treatment of rickets (7,8). Through experimentation with puppies, Mellanby declared a clear role for diet in the etiology of rickets (8). Elmer McCollum and his colleagues at Johns Hopkins University can be credited with determining the nutritional factor deficient in diets leading to rickets, then named vitamin D (7,9,10).

Recognition of the role of sunlight in the development of rickets dates back to the mid- 1800s with reports of lack of sunlight and poor diet leading the rickets (5). In 1890, Palm -- a European researcher, noted that despite a superior diet and sanitary living conditions, infants living in Britain had an increased incidence of rickets when compared to infants living in the tropics(11). He, then recommended sun-baths for prevention and treatment of rickets (11). Finally in the 1920s, Park (12) and Harriette Chick and her coworkers (13) were able to confirm the use of cod liver oil (vitamin D) supplementation and sun exposure for the prevention and treatment of rickets. By the 1930s, routine vitamin D supplementation, sun exposure, and milk fortification in the United States led to an eradication of rickets (12,14).

Unfortunately, nutritional rickets reemerged in the 1980s, particularly among the African American and other darkly pigmented populations. The recurring thread amongst the reported cases is that the infants are darkly pigmented, often living at higher latitudes, and are exclusively breastfed without vitamin D supplementation beyond six months of age (15). This finding led to a revised American Academy of Pediatrics (AAP) statement in 2003 recommending 200 IU of vitamin D supplementation to all infants receiving less than 500ml of fortified formula per day to begin within the first two months of life (16). Continued reports of rickets, limited dietary sources of vitamin D, inadequate sun exposure for vitamin D synthesis, and an enhanced understanding of vitamin D physiology and its actions have led to the most recent revision of the AAP statement in 2008. The current recommendations are for all infants and children to be supplemented with a minimum of 400 IU per day of vitamin D beginning in the first few days of life (17).

Vitamin in Pregnancy

It had been known for decades that maternal vitamin D concentration largely determines the vitamin D status of the developing fetus and neonate. Despite this observation, the Institute of Medicine in 1997 (18) and a Cochrane Review in 2002 (19) concluded that little data exist regarding maternal vitamin D supplementation during pregnancy. During pregnancy, a women needs vitamin D not only to maintain her health status, but also that of the placenta and developing fetus.

Adult vitamin D deficiency is widespread. Recent data indicates that an ideal level for 25(OH)D is greater than 40 ng/mL or 100 nmol/L (20). The first report of widespread vitamin D deficiency in women of child bearing age came from the United States Center for Disease Control (CDC) NHANES III report revealing that 42 percent of African American women had 25(OH)D levels below 15 ng/mL or 37.5 nmol/L (21), and more recent data in a large cohort in SC suggests this prevalence is around 75 percent (22).

A long standing unawareness of the short and long term health consequences of vitamin D insufficiency has led to widespread insufficiencies in most populations. A representation of the prevalence of vitamin D insufficiency around the world is as follows: 8 percent in Western women in the Netherlands (23), 18 percent in the United Kingdom (24), 25 percent in the United Arab Emirates (25), 42 percent in Northern India (26), 46 percent in Canada (27), 50 percent in non-European ethnic minority women in South Wales (28), 59-84 percent in women with darker igmentation in the Netherlands (23), 61 percent in New Zealand (29), 71 percent in Pakistani women in Norway (30), and 80 percent in Iran (31).

A recent focus on fetal origin of adult disease has led to investigation of the exposure to vitamin D insufficiency during fetal development and its relationship to later disease processes. Specifically, there is growing evidence of vitamin D's effect in utero on fetal bone (32,33); later risk for schizophrenia (34-39), multiple sclerosis (40,41), childhood and adult cancers (42,43), autoimmune diseases and inflammatory disease states such as lupus (44), rheumatoid arthritis (45), and diabetes (46,47); concern about maternal and early infant vitamin D status is justified (1,48,49). Other support for the effect of vitamin D during fetal development comes from the work of Zimmermann, et al. (50), who showed a significant correlation between IL-10 (anti-inflammatory cytokine) and 25(OH)D status at birth. In addition to effects on the fetus, an article published by Bodnar in 2007 proposes that vitamin D deficiency may act as an independent risk factor for maternal preeclampsia (a form of toxemia of pregnancy; a condition that may develop during pregnancy leading to severely elevated blood pressure, large amounts of protein in the urine, and can progress to seizures) (51). It is becoming increasingly clear that adequate maternal vitamin D status is essential not only to maternal well being but also to fetal development during pregnancy. Obstetrical healthcare providers should consider assessing maternal vitamin D status by measuring serum 25-OH-D levels in pregnant patients. If found to be insufficient, a mother should be supplemented with vitamin D3 to reach sufficient 25-OH-D concentrations (greater than 32 ng/mL or 80 nmol/L) (52-56).

Vitamin D and Human Milk

The natural progression from placental nutrition during pregnancy is human milk provided after delivery(57). Human milk is considered the ideal nutrition for the neonate and growing infant with one caveat – it lacks sufficient concentrations of one essential vitamin – vitamin D (16). Without adequate vitamin D supplementation, the infant is at risk for developing rickets, a disease most often associated with exclusive breastfeeding.

One may wonder why the ideal infant nutrition would be deficient in an essential vitamin for normal human development. Over the centuries, society has changed from one with significant sun exposure allowing synthesis of maternal vitamin D in the skin to one in which people remain indoors or block the sun with clothing, lotions, and hats to avoid the possibility of sun damage. Unfortunately, this has resulted in widespread maternal vitamin D deficiency. With lactating mothers having inadequate stores of vitamin D for themselves or their infants, vitamin D deficient human milk ensues.

Even with maternal supplementation of recommended daily intake of 400 IU per day of vitamin D3, human milk contains only 33-68 IU/L, far below the required 200-800 IU per day to prevent rickets (58-61). With an evolving understanding of vitamin D sufficiency and vitamin D toxicity and the advent of higher doses for supplementation of vitamin D to achieve sufficiency in adults, the concept of maternal supplementation to achieve infant vitamin D sufficiency has developed. Ongoing investigations to determine a safe yet effective vitamin D dose to maintain maternal and infant vitamin D sufficiency are underway (62). Prior investigations have demonstrated the ability to improve vitamin D concentration in human milk through exposure to UVB radiation as well as through maternal supplementation (58,59,61,63).

Vitamin D and Lactation

Infants who are exclusively breastfed without vitamin D supplementation or adequate sunlight exposure have an increased risk of developing vitamin D deficiency or even rickets (64-71). Darkly pigmented children in particular are at risk, in part due to maternal insufficiency or frank deficiency resulting in an infant with vitamin D insufficiency at birth and in reduced vitamin D concentrations in the mother's milk (72). The evaluation of the efficacy and safety of maternal vitamin D supplementation to achieve vitamin D-sufficient human milk is limited secondary to the misconception that vitamin D toxicity occurs at a dose of 4,000 IU per day vitamin D (18,73). Early trials in the 1980s with maternal supplementation of 500-1000 IU per day of vitamin D showed no significant change in human milk concentrations of vitamin D (63,69,74,75) but more recent trials support the use of daily maternal supplementation for maintenance of maternal and infant vitamin D sufficiency (59,61). (See table 1.) Although results of recent investigations are promising in that vitamin D concentrations can be increased in milk of lactating women by using large vitamin D supplements, the pilot studies in lactating women must be validated and demonstrated to be safe in larger, more representative populations of women across the United States and throughout the world. Large prospective, randomized controlled trials are currently underway, but until their completion, high-dose vitamin D supplementation for all breastfeeding mothers cannot be recommended. Infant supplementation therefore remains necessary at this time.

From (29)Judkins, A.E.C. (2006); and (30) Brunvard, L., Shah, S.S., Bergstroem, S. (1998).
Table 1. Contemporary Clinical Trials of
Vitamin D Supplementation during Lactation
Maternal vitamin D supplementation Infant vitamin D supplementation Maternal serum 25(OH)D (ng/ml) Milk Antirachitic Activity (IU/L) Infant serum 25(OH)D (ng/ml)
2,000 IU/day 0 36.1 69.2 27.8
4,000 IU/day 0 44.5 134.6 30.8
6,000 IU/day 0 58.8 873 46
400 IU/day 300 IU/day 38.4 45.6 - 78.6 43

Vitamin D Supplementation of the Breastfeeding Infant

In 2003, in accordance with the National Academy of Sciences recommendations, the AAP reduced its previous recommendation for 400 IU of vitamin D per day for infants to supplementation of 200 IU of vitamin D per day to all breastfed infants in the first 2 months of life, at a time when breastfeeding was well established (16) . This was in agreement with a 1997 report from the Institute of Medicine as well (18). The change was based principally on data from the United States, Norway, and China showing that 200 IU of vitamin D would prevent physical signs of vitamin D deficiency as well as maintain 25-OHD levels in the sufficient range, greater than or equal to 11 ng/mL or 27.5 nmol/L (16). Research has shown that breastfed infants can maintain sufficient vitamin D status solely through adequate sunlight exposure (76,77); however, concerns regarding the future development of skin cancers and subsequent application of sunscreens and protective barriers makes adequate sun exposure for vitamin D synthesis unlikely in most infants (17,78).

Since the implementation of the AAP recommendations in 2003 (79), there has been increased information in adults linking vitamin D insufficiency to other biochemical markers involved in bone mineralization, calcium absorption, insulin resistance, and the function of the immune system (17,80,81). As a result, concerns have arisen regarding the adequacy of supplementation with only 200 IU of vitamin D. (See table 2.) In fact, in response to these findings, new definitions of vitamin D deficiency and insufficiency have developed. For adults, vitamin D deficiency is now defined as a 25-OHD level less than 20 ng/mL or 50 nmol/L, and vitamin D insufficiency as a 25-OH-D level in the range of 20 ng/mL 50 nmol/L to 32 ng/mL or 80 nmol/L; therefore, vitamin D sufficiency is defined as a 25-OH-D level of greater than 32 ng/mL or 80 nmol/L.

Adapted from AAP Vitamin D Statement, Table 1 (17,80,81).
Table 2. Vitamin D Deficiency
Clinical Signs and Stages of Vitamin D Deficiency
1. Decreased absorption of intestinal calcium; urinary loss of phosphorus; normal calcium levels maintained Stage 1
2. Bone demineralization to maintain normal serum calcium levels Stage 2
3. Decreased levels of calcium and phosphorus in the blood Stage 3
Disease States Associated with Vitamin D Deficiency
  1. Autoimmune Diseases (through Vitamin D's actions on the innate immune system)
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
    • Multiple Sclerosis
    • Diabetes Mellitus, Type I
    • Crohn's Disease
  2. Cancer
    • Head and Neck
    • Breast
    • Prostate
    • Colon
  3. Cardiovascular Disease (through inflammation)
  4. Alteration in Mobility
  5. Insulin Resistance

Definitive ranges for infants and children have yet to be declared, but research has shown that supplementation with 200 IU per day of vitamin D is inadequate to achieve 25-OH-D levels greater than 20 ng/mL or 50 nmol/L while supplementation with 400 IU per day of vitamin D is adequate to achieve 25-OHD levels of at least 20 ng/mL or 50 nmol/L (17,59,82). This premise is based on the following well established facts:

  1. Vitamin D deficiency can occur early in life, particularly when many pregnant women themselves are deficient.
  2. 25-OH-D levels of unsupplemented breastfed infants are often below 20 ng/mL or 50 nmol/L, particularly in winter months and latitudes farther from the equator, probably as a result of maternal deficiency.
  3. Adequate sunlight exposure in a given infant to achieve adequate vitamin D synthesis is difficult to determine and often not achieved.
  4. 25-OHD levels can be maintained greater than 20 ng/mL or 50 nmol/L in breastfed infants with vitamin D supplementation of 400 IU per day of vitamin D (17).

In light of these observations, the AAP recently amended its previous recommendation for vitamin D supplementation of infants and children (17). The current recommendation reads, "A supplement of 400 IU/day of vitamin D should begin within the first few days of life and continue throughout childhood. Any breastfeeding infant, regardless of whether he or she is being supplemented with formula, should be supplemented with 400 IU of vitamin D." Vitamin D preparations either in vitamin D-only or multi-vitamin supplements are readily available and inexpensive. (See table 3.)

Table 3. Oral Vitamin D Preparations Currently Available in the United States (in Alphabetical Order)
Preparationsa Dosage
Bio-D-Mulsion (Biotics Research Laboratory, Rosenberg, TX; www.bioticsresearch.com) 1 drop contains 400 IUb; also comes in a preparation of 2000 IU per dropb; corn oil preparation
Carlson Laboratories (Arlington Heights, IL; www.carlsonlabs.com) 1 gel cap contains 400 IU; also comes in 2000-IU and 4000-IU gel caps and in single-drop preparations of 400-IU, 1000-IU, and 2000-IUb; safflower oil preparation
Just D (Sunlight Vitamins Inc., Distributed by UnitDrugCo, Centennial, CO., www.sunlightvitamins.com) 1 mL contains 400 IU; corn oil preparation
Multivitamin preparations; polyvitamins (A, D, and K vitamin preparations) 1 mL contains 400 IU; variable preparations that include glycerin and water; may also contain propylene glycol and/or polysorbate 80

Note that higher-dose oral preparations may be necessary for the treatment of those with rickets in the first few months of therapy or for patients with chronic diseases such as fat malabsorption (cystic fibrosis) or patients chronically taking medications that interfere with vitamin D metabolism (such as antiseizure medications).

  1. A study by Martinez et al. showed that newborn and older infants preferred oil-based liquid preparations to alcohol-based preparations.
  2. Single-drop preparations may be better tolerated in patients with oral aversion issues, but proper instruction regarding administration of these drops must be given to the parents or care provider, given the increased risk of toxicity, incorrect dosing, or accidental ingestion.
  3. The cost of vitamin D-only preparations may be more than multivitamin preparations and could be an issue for health clinics that dispense vitamins to infants and children. The multivitamin preparation was the only preparation available until recently; therefore, there is a comfort among practitioners in dispensing multivitamins to all age groups.

From the AAP statement (17); reproduced with permission.

As human milk has repeatedly been reaffirmed as the ideal nutrition for infants' healthy growth and development with the exception of inadequate concentrations of vitamin D, the ideal situation would be to improve the nutritional status of the human milk to avoid the need for any supplementation. Early investigation to improve maternal vitamin D status, thereby improving the nutritional status of a mother's milk, is promising, but a well established dose to achieve this goal has not yet been determined. In addition, we know that vitamin D insufficiency affects multiple organ systems including the immune system, bone mineralization, and the cardiovascular system based upon adult literature, but the long term implications for fetuses and infants developing in a vitamin insufficient state have not been studied. A current area of interest is the fetal origin of adult disease. How does vitamin D insufficiency and frank deficiency during early development of an embryo and into infancy impact the innate programming for adult disease? In order to answer these questions further research is needed, particularly in the areas of vitamin D in relation to pregnancy, lactation, and long term consequences for the infant.


As a result of inadequate nutritional vitamin D intake and global concerns regarding sun exposure as well as changes in the definition of vitamin D sufficiency, vitamin D deficiency and insufficiency have become commonplace. Of upmost importance to our field of medicine is the incidence of vitamin D deficiency during pregnancy and lactation, which then impacts the fetus and newborn. Literature clearly supports supplementation of pregnant women to improve their health status as well as that of their developing fetus. Although supplementation of a lactating mother should be recommended for her health benefits, the dose at which supplementation of the mother would also benefit the breastfeeding infant has yet to be clearly defined. Therefore, at this time, supplementation of the breastfeeding infant with 400 IU of vitamin D per day should continue to be recommended.


1. Hess, A. (1929). Rickets including osteomalacia and tetany. Philadelphia, PA: Lea & Febiger.
2. Ruhrah, J. (1925). Pedatrics of the past. New York, NY: Paul B. Hoeber, Inc,.
3. Still, G. (1931). The history of pediatrics. The progress of the study of children up to the end of the XVIIIth century. London, United Kingdom: Oxford University Press, Humphrey Milford.
4. Dunn, P. (1998). Francis Glisson (1597-1677) and the "discovery" of rickets. Arch Dis Child Fetal Neonatal Ed, 78, F154-55.
5. Rajakumar, K. (2003). Vitamin D, cod-liver oil, sunlight, and rickets: A historical perspective. Pediatrics, 112(2),e132-35.
6. Hess, A. (1922). Infantile rickets: the significance of clinical, radiographic, and chemical explanations in its diagnosis and incidence. Am J Dis Child, xxiv, 327.
7. McCollum, E. (1957). A History of Nutrition. Cambridge, MA: Riverside Press.
8. Mellanby, E. (1919). An experimental investigation on rickets. Lancet, 1, 407-12.
9. McCollum, E. (1964). From Kansas Farm Boy to Scientist. Lawrence, KS: University of Kansas Press.
10. McCollum, E., Simmonds, N., Becker, J. E., et al. (1922). Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem, 53, 293-312.
11. Palm, T. (1890). The geographical distribution and aetiology of rickets. Practitioner, 45, 270-79, 321-42.
12. Park, E. (1923). The etiology of rickets. Physiol, Rev 3, 106-19.
13. Chick, H. (1976). Study of rickets in Vienna 1919-1922. Med Hist, 20, 41-51.
14. Park, E. A. (1940). The therapy of rickets. JAMA, 115(5), 370-79.
15. Rajakumar, K., & Thomas, S. B. (2005). Reemerging Nutritional Rickets: A Historical Perspective. Arch Pediatr Adolesc Med, 159(4), 335-41.
16. Gartner, L., Greer, F., American Academy of Pediatrics Section on Breastfeeding Medicine & Committee on Nutrition. (2003). Prevention of Rickets and Vitamin D Deficiency: New Guidelines for Vitamin D Intake. Pediatrics, 111(4), 908-10.
17. Wagner, C.L, Greer, F. R., American Academy of Pediatrics Section on Breastfeeding Medicine & Committee on Nutrition. (2008). Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents. Pediatrics, 122(5), 1142-52.
18. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board IoM. (1997). Calcium, phosphorus, magnesium, vitamin D and fluoride. Dietary Reference Intakes. Washington, DC: National Academy Press.
19. Mahomed, K., & Gulmezoglu, A. M. (2002). Vitamin D supplementation in pregnancy (Cochrane Review). The Cochrane Library. Oxford: Update Software.
20. Holick, M. (2007). Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging, 24, 1017-29.
21. Nesby-O'Dell, S., Scanlon, K., Cogswell, M., et al. (2002). Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey: 1988-1994. Amer J Clin Nutr, 76, 187-92.
22. Wagner, C, Johnson, D., Hulsey, T., et al. (2008). Vitamin D Deficiency (VDD) during Pregnancy: At Epidemic Proportions in SC (abstract). Pediatr Res.
23. van der Meer, I. M., Karamali, N. S., Boeke, A. J. P., et al. (2006). High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr, 84(2), 350-53.
24. Javaid, M. K., Crozier, S. R., Harvey, N. C., et al. (2006). Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. The Lancet, 367(9504), 36-43.
25. Dawodu, A., Agarwal, M., & Patel, M. (ea 1997). Serum 25-hydroxyvitamin D and calcium homeostasis in the United Arab Emirates mothers and neonates: a preliminary report. Middle East Paediatr, 2, 9-12.
26. Sachan, A., Gupta, R., Das, V., et al. (2005). High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. Am J Clin Nutr, 81(5), 1060-64.
27. Weiler, H., Fitzpatrick-Wong, S., & Veitch, R. (ea 2005). Vitamin D deficiency and whole-body and femur bone mass relative to weight in healthy newborns. Canadian Medical Association Journal, 172(6), 757-61.
28. Datta, S., Alfaham, M., & Davies, D. P. (ea 2002). Vitamin D deficiency in pregnant women from a non-European ethnic minority population-an interventional study. BJOG: An International Journal of Obstetrics & Gynaecology, 109(8), 905-08.
29. Judkins, A. (EC 2006). Vitamin D deficiency in pregnant New Zealand women. New Zealand Medical Journal, 119, U2144.
30. Brunvard, L., Shah, S. S. & Bergstroem, S. (ea 1998). Vitamin D deficiency in pregnancy is not associated with obstructed labor. A study among Pakistani women in Karachi. Acta Obstet Gynecol Scand, 77, 303-06.
31. Bassir, M., Laborie, S., Lapillonne, A., et al. (2001). Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatrica, 90(5), 577 - 79.
32. Brooke, O. G., Brown, I. R. F., Bone, C. D. M., et al. (1980). Vitamin D supplements in pregnant Asian women: Effects on calcium status and fetal growth. Brit Med J, 1, 751-54.
33. Namgung, R., Tsang, R. C., Specker, B. L., et al. (1993). Reduced serum osteocalcin and 1,25-dihydroxyvitamin D concentrations and low bone mineral content in small for gestational age infants: evidence of decreased bone formation rates. J Pediatr, 122(2), 269-75.
34. McGrath, J. (1999). Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res, 49, 173-77.
35. McGrath, J., Selten, J. P., & Chant, D. (2002). Longterm trends in sunshine duration and its association with schizophrenia birth rates and age at first registration-data from Australia and the Netherlands. Schizophr Res, 54, 199-212.
36. Eyles, D., Brown, J., MacKay-Sim, A., et al. (2003). Vitamin D3 and brain development. Neuroscience, 118(3), 641-53.
37. Brown, J., Bianco, J., McGrath, J., et al. (2003). 1,25- Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. . Neurosci Lett, 343,139-43.
38. Burkert, R., McGrath, J., & Eyles, D. (2003). Vitamin D receptor expression in the embryonic rat brain. Neurosci Res Commun, 33,63-71.
39. Ko, P., Burkert, R., McGrath, J., et al. (2004). Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cyle during rat brain development. Dev Brain Res, 153, 61-68.
40. Hayes, C. E. (2000). Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc, 59, 531-35.
41. Munger, K., Zhang, S., O'Reilly, E., et al. (2004). Vitamin D intake and incidence of multiple sclerosis. Neurology, 62, 60-65.
42. Holick, M. F. (2004). Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr, 79, 362-71.
43. Lappe, J. M., Travers-Gustafson, D., Davies, K. M., et al. (2007). Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr, vol. 85, pp 1586-91.
44. Kamen, D. L., Cooper, G. S., Bouali, H., et al. (2006). Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev, 5(2), 114-7.
45. Merlino, L. A., Curtis, J., Mikuls, T. R., et al. (2004). Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum, 50(1), 72-7.
46. Pittas, A. G., Lau, J., Hu, F. B., et al. (2007). The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 92(6).
47. Arnson, Y., Amital, H., Shoenfeld, Y. (2007). Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis, 66, 1137-42.
48. McGrath, J., Selten, J-P, Chant, D. (2002). Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration— data from Australia and the Netherlands. Schizophrenia Research, 54(3),199-212.
49. Weiler, H. A., Leslie, W. D., Krahn, J., et al. (2007). Canadian Aboriginal Women Have a Higher Prevalence of Vitamin D Deficiency than Non-Aboriginal Women Despite Similar Dietary Vitamin D Intakes. J. Nutr, 137(2), 461-65.
50. Zittermann, A. , Dembinski, J., Stehle, P. (2004). Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr Allergy Immunol, 15, 242-46.
51. Bodnar, L. M., Catov, J. M., Simhan, H. N., et al. (2007). Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia. J Clin Endocrinol Metab, 92(9), 3517-22.
52. Hathcock, J. N., Shao, A., Vieth, R., et al. (2007). Risk assessment for vitamin D. Am J Clin Nutr, 85(1), 6-18.
53. Hollick, M. (2007). Vitamin D Deficiency. New England Journal of Medicine, 357(3), 266-81.
54. Vieth, R., Bischoff-Ferrari, H., Boucher, B. J., et al. (2007). The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr, 85(3), 649-50.
55. Hollis, B. W., (2005). Circulating 25-Hydroxyvitamin D Levels Indicative of Vitamin D Sufficiency: Implications for Establishing a New Effective Dietary Intake Recommendation for Vitamin D. J. Nutr, 135(2), 317-22.
56. Hollis, B., Wagner, C. L., Kratz, A., et al. (2005). Normal serum vitamin D levels. Correspondence. New England Journal of Medicine, 352(5), 515-16.
57. Wagner, C. L., Taylor, S. N., Johnson, D. (2008). Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin Rev Allergy Immunol, 34(2), 191-204.
58. Greer, F., Hollis, B. W., Cripps, D. J., et al. (1984). Effects of maternal ultraviolet B irradiation on vitamin D content of human milk. Journal of Pediatrics, 105, 431-33.
59. Wagner, C., Hulsey, T. C., Fanning, D., et al. (2006). High dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a six-month follow-up pilot study. Breastfeeding Medicine, 1(2), 59-70.
60. Hollis, B. W. (1983). Individual quantitation of vitamin D2, vitamin D3, 25(OH)D2, and 25(OH)D3 in human milk. Analytical Biochemistry, 131, 211-19.
61. Hollis, B. W., Wagner, C. L. (2004). Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr, 80(6), 1752S-58.
62. Hollis, B. W. (2007). Vitamin D requirement during pregnancy and lactation. J Bone Miner Res, 22, V39-44.
63. Ala-Houhala, M., Koskinen, T., Terho, A., et al. (1986). Maternal compared with infant vitamin D supplementation. Arch Dis Child, 61, 1159-63.
64. Mylott, B., Kump, T., Bolton, M. L., et al. (2004). Rickets in the Dairy State. WMJ, 103(5), 84-87.
65. Kreiter, S. R., Schwartz, R. P., Kirkman, H. N, et al. (2000). Nutritional rickets in African American breast-fed infants. The Journal of Pediatrics, 137(2), 153-57.
66. Pugliese, M. T., Blumberg, D. L., Hludzinski, J., et al. (1998). Nutritional Rickets in Suburbia. J Am Coll Nutr, 17(6), 637-41.
67. Sills, I., Skuza, K. A., Horlick, M. N., et al. (1994). Vitamin D deficiency rickets: reports of its demise are exaggerated. Clin Pediatr (Phila), 33(8), 491-93.
68. Binet, A., Kooh, S. W. (1996). Persistence of Vitamin D-deficiency rickets in Toronto in the 1990s. Can J Public Health, 87(4), 227-30.
69. Ala-Houhala, M. (1985). 25(OH)D levels during breastfeeding with or without maternal or infantile supplementation of vitamin D. J Pediatr Gastroenterology Nutri, 4, 220-26.
70. Daaboul, J., Sanderson, S., Kristensen, K., et al. (1997). Vitamin D deficiency in pregnant and breast-feeding women and their infants. J Perinatology, 17(1), 10-14.
71. Weisburg, P., Scanlon, K. S., Li, R., et al. (2004). Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr, 80(suppl), 1697S-70S.
72. Cancela, L., LeBoulch, N., Miravet, L. (1986). Relationship between the vitamin D content of maternal milk and the vitamin D status of nursing women and breastfed infants. J Endocrinol, 110, 43-50.
73. Narang, N., Gupta, R., Jain, M., et al. (1984). Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India, 32, 185-86.
74. Takeuchi, A., Okano, T., Tsugawa, H., et al. (1989). Effects of ergocalciferol supplementation on the concentration of vitamin D and its metabolites in human milk. J Nutr, 119, 1639-46.
75. Rothberg, A., Pettifor, J. M., Cohen, D. F., et al. (1982). Maternal-infant vitamin D relationships during breast-feeding. Journal of Pediatrics, 101, 500-03.
76. Specker, B. L., Valanis, B., Hertzberg, V., et al. (1985). Sunshine exposure and serum 25-hydroxyvitamin D concentrations in exclusively breast-fed infants. J Pediatr, 107(3), 372-6.
77. Ho, M. L., Yen, H. C., Tsang, R. C., et al. (1985). Randomized study of sunshine exposure and serum 25- OHD in breast-fed infants in Beijing, China. J Pediatr, 107(6), 928-31.
78. American Academy of Pediatrics. (1999). Policy Statement. Ultraviolet light: A hazard to children (RE9913). Pediatrics, 104(2), 328-33.
79. Gartner, L., Greer, F., American Academy of Pediatrics Section on Breastfeeding Medicine & Committee on Nutrition. (2003). Prevention of rickets and vitamin D deficiency: New guidelines for vitamin D intake. Pediatrics,111(4), 908-10.
80. Taylor, S. N., Wagner, C. L., Hollis, B. W. (2008). Vitamin D supplementation during lactation to support infant and mother. J Am Coll Nutr, 27(6):690-701.
81. Wagner, C. L., Taylor, S. N., Hollis, B. W. (2008). Does vitamin D make the world go 'round'? Breastfeed Med, 3(4), 239-50.
82. Pittard, W. B., Geddes, K. M., Hulsey, T. C., et al. (1991). How much vitamin D for neonates? Amer J Dis Child, 145, 1147-49.

Page last edited .

Bookmark and Share